Analyst Rating Update on ResMed (RMD)

ResMed (RMD) : Zacks Investment Research ranks ResMed (RMD) as 3, which is a Hold recommendation. 1 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 1 other analysts are mildly bullish on the stock and favor a Buy. 3 more believe that the stock has more downside risks, hence they propose a Strong Sell. A total of 4 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 9 research analysts is 3.28, which indicates as a Hold.

ResMed (RMD) has been rated by 7 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $70 and the lowest price target forecast is $50. The average forecast of all the analysts is $60.86 and the expected standard deviation is $7.48.

Company shares have received an average consensus rating of Hold for the current week


ResMed (NYSE:RMD): The stock opened at $69.39 on Wednesday but the bulls could not build on the opening and the stock topped out at $69.57 for the day. The stock traded down to $68.64 during the day, due to lack of any buying support eventually closed down at $68.80 with a loss of -0.84% for the day. The stock had closed at $69.38 on the previous day. The total traded volume was 871,615 shares.

ResMed Inc. is engaged in the development, manufacturing, distribution and marketing of medical products for the diagnosis, treatment and management of respiratory disorders, with a focus on sleep-disordered breathing (SDB). The Company develops various products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. It produces continuous positive airway pressure, variable positive airway pressure and AutoSet systems for the titration and treatment of SDB. Its products also include S9 Escape, AirSense 10 Elite, AirSense 10 CPAP, S9 VPAP S, S9 VPAP ST, S9 VPAP Adapt, S9 VPAP ST-A, S9 VPAP COPD and AirCurve 10 V Auto, among others. It markets sleep recorders for the diagnosis and titration of SDB in sleep clinics and hospitals. Its products include Quattro FX, Swift FX for Her, Mirage FX for Her, Pixi Pediatric Mask, Quattro FX for Her, Swift FX Bella, Swift FX Nano, AirFit N10 and Apnealink Air.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.